₹3.39
(Market cap
₹2,056 Cr
Recently Viewed
Clear AllMarket cap
₹2,056 Cr
Revenue (TTM)
₹1,778 Cr
P/E Ratio
--
P/B Ratio
2.1
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-61 Cr
ROE
5.8 %
ROCE
10.6 %
Industry P/E
35.96
EV/EBITDA
16.2
Debt to Equity
0.7
Book Value
₹50.2
EPS
₹0.5
Face value
1
Shares outstanding
192,091,613
CFO
₹603.93 Cr
EBITDA
₹1,258.28 Cr
Net Profit
₹308.15 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Camlin Fine Sci
| -27.9 | -9.9 | -21.1 | -35.2 | -13.8 | -4.4 | 0.6 |
|
BSE Commodities
| 6.5 | 11.5 | 6.6 | 15.8 | 18.5 | 13.9 | 16.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Camlin Fine Sci
| 6.6 | -2.4 | -15.2 | 23.1 | 4.5 | 42.0 | 55.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Camlin Fine Sci
|
107.0 | 2,055.8 | 1,778.0 | -64.7 | 3.5 | 1 | -- | 2.1 |
| 470.4 | 17,045.6 | 8,045.0 | 378.0 | 7.8 | 6.6 | 45.1 | 2.9 | |
| 1,183.3 | 15,690.1 | 1,088.6 | 215.8 | 27.4 | 9.8 | 72.7 | 6.5 | |
| 1,343.3 | 15,297.8 | 2,229.8 | 229.1 | 18.1 | 5.7 | 88.9 | 4.7 | |
| 1,745.5 | 23,819.7 | 7,946.4 | 533.3 | 8.9 | 9.9 | 44.7 | 4.2 | |
| 5,086.0 | 15,581.4 | 2,347.3 | 398.8 | 17.9 | 16.4 | 39.3 | 6.1 | |
| 4,051.5 | 9,417.3 | 2,071.4 | 307.8 | 17.4 | 12.6 | 30.6 | 3.7 | |
| 699.0 | 11,138.5 | 4,260.9 | 265.7 | 9.0 | 9.2 | 41.9 | 3.6 | |
| 3,163.3 | 12,358.5 | 2,455.7 | 286.6 | 18.6 | 25.6 | 41.1 | 9.4 | |
| 1,312.7 | 13,616.0 | 2,271.4 | 442.9 | 24.7 | 15.5 | 30.7 | 4.5 |
2 min read•By Yash Rohra
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which... include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its prodycrts under the Xtendra, Nasure, Ezential, adorr, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India. Read more
Incorporated
1993
Chairman
Ashish Dandekar
Managing Director
N Momaya
Group
S Dandekar
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Camlin Fine Sciences Ltd is ₹107.01 (NSE) and ₹107.02 (BSE) as of 22-Apr-2026 IST. Camlin Fine Sciences Ltd has given a return of -13.79% in the last 3 years.
Since, TTM earnings of Camlin Fine Sciences Ltd is negative, P/E ratio is not available.
The P/B ratio of Camlin Fine Sciences Ltd is 2.13 times as on 22-Apr-2026, a 4 discount to its peers’ median range of 2.21 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
3.55
|
|
2024
|
0.00
|
1.85
|
|
2023
|
38.39
|
2.70
|
|
2022
|
36.09
|
3.35
|
|
2021
|
34.97
|
3.62
|
The 52-week high and low of Camlin Fine Sciences Ltd are Rs 333.30 and Rs 96.21 as of 22-Apr-2026.
Camlin Fine Sciences Ltd has a market capitalisation of ₹ 2,056 Cr as on 22-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Camlin Fine Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.